HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinico-pharmacological study of neurotropic agents in neurogenic diseases of the cardiovascular system and stomach].

Abstract
It has been established in experiments that as visceral pathology arising during excess exposures advances, the deficiency of energy resources develops in the tissues of damaged organs. Application of the agents that normalize the function of the sympathetic nervous system (L-DOPA) and stimulate energy formation processes (ethimizol) accelerated reparative processes in damaged stomach and myocardium. Application of L-DOPA and ethimizol to the treatment of peptic ulcer patients produced a good therapeutic effect--an increase in the creatine phosphate content in the gastric mucosa and removal of the niche symptom in 80% of cases.
AuthorsI S Zavodskaia, E V Moreva, E A Migas, V V Bul'on, V P Novikov
JournalFarmakologiia i toksikologiia (Farmakol Toksikol) 1983 May-Jun Vol. 46 Issue 3 Pg. 17-20 ISSN: 0014-8318 [Print] Russia (Federation)
Vernacular TitleKliniko-farmakologicheskoe izuchenie nekotorykh neĭrotropnykh sredstv pri neĭrogennykh zabolevaniiakh serdechno-sosudistoĭ sistemy i zheludka.
PMID6861984 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Levodopa
  • Etimizol
Topics
  • Animals
  • Cardiovascular Diseases (drug therapy, metabolism)
  • Drug Evaluation
  • Drug Evaluation, Preclinical
  • Energy Metabolism (drug effects)
  • Etimizol (pharmacology, therapeutic use)
  • Humans
  • Levodopa (pharmacology, therapeutic use)
  • Male
  • Rabbits
  • Rats
  • Stomach Ulcer (drug therapy, metabolism)
  • Sympathetic Nervous System (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: